1. Home
  2. FGEN vs DTST Comparison

FGEN vs DTST Comparison

Compare FGEN & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • DTST
  • Stock Information
  • Founded
  • FGEN 1993
  • DTST 2001
  • Country
  • FGEN United States
  • DTST United States
  • Employees
  • FGEN N/A
  • DTST N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • FGEN Health Care
  • DTST Technology
  • Exchange
  • FGEN Nasdaq
  • DTST Nasdaq
  • Market Cap
  • FGEN 33.5M
  • DTST 28.2M
  • IPO Year
  • FGEN 2014
  • DTST N/A
  • Fundamental
  • Price
  • FGEN $5.25
  • DTST $3.56
  • Analyst Decision
  • FGEN Strong Buy
  • DTST
  • Analyst Count
  • FGEN 1
  • DTST 0
  • Target Price
  • FGEN $250.00
  • DTST N/A
  • AVG Volume (30 Days)
  • FGEN 57.0K
  • DTST 33.0K
  • Earning Date
  • FGEN 08-05-2025
  • DTST 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • DTST N/A
  • EPS Growth
  • FGEN N/A
  • DTST N/A
  • EPS
  • FGEN N/A
  • DTST 0.02
  • Revenue
  • FGEN $6,996,000.00
  • DTST $25,219,312.00
  • Revenue This Year
  • FGEN N/A
  • DTST $12.57
  • Revenue Next Year
  • FGEN N/A
  • DTST $9.29
  • P/E Ratio
  • FGEN N/A
  • DTST $145.21
  • Revenue Growth
  • FGEN N/A
  • DTST N/A
  • 52 Week Low
  • FGEN $4.50
  • DTST $2.93
  • 52 Week High
  • FGEN $38.25
  • DTST $6.95
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 32.31
  • DTST 50.36
  • Support Level
  • FGEN $4.85
  • DTST $3.33
  • Resistance Level
  • FGEN $5.77
  • DTST $3.48
  • Average True Range (ATR)
  • FGEN 0.57
  • DTST 0.16
  • MACD
  • FGEN -0.07
  • DTST 0.01
  • Stochastic Oscillator
  • FGEN 13.22
  • DTST 54.39

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: